Veterinary Consolidator Ownership Map 2026: Who Owns Whom
Veterinary Consolidator Ownership Map 2026: Who Owns Whom
Key takeaways
- Every major veterinary consolidator has a private equity sponsor behind it — with one exception. Mars Veterinary Health (VCA, Banfield, BluePearl) is family-owned by Mars, Inc., not PE-backed. Every other significant platform has a PE firm with capital to deploy and a fund life to manage.
- The sponsor matters as much as the brand name on the offer. Shore Capital backs Mission Pet Health. JAB Holding backs NVA. Oak Hill and Harvest back VetCor. KKR backs PetVet. AEA Investors and ADIA back AmeriVet. Each sponsor has a different fund lifecycle, acquisition appetite, and exit thesis — all of which shape the offer a seller sees.
- Mission Pet Health is the 2025–2026 headline story. The merger of Southern Veterinary Partners and Mission Veterinary Partners — both Shore Capital platforms — created a 850-plus hospital national operation. It is among the most active acquirers right now.
- NVA has split into two distinct businesses. JAB is running NVA (general practice) and Ethos Veterinary Health (specialty and emergency) as separate entities, with IPOs as the stated exit path.
- A single direct offer from one consolidator is almost never the market-clearing number. A competitive process that surfaces multiple consolidators bidding at the same time is what actually moves the multiple — and the ownership map helps you understand who is at that table and what each sponsor’s incentives are.
The offer came in on a Tuesday. A regional platform, well-known brand, professional deal team.
The number looked reasonable on the surface. But the vet who brought it to me over dinner hadn’t looked one level up — hadn’t asked who the actual decision-maker behind the offer was, or what that decision-maker’s timeline looked like, or how hungry they were to deploy capital right now versus in six months.
That one level up is the PE sponsor. And it changes everything about how you read the offer.
Every major veterinary consolidator in the US market is a brand name layered on top of a private equity structure. The brand is what your clients see.
The sponsor is what a sophisticated seller needs to understand before they decide how to respond to — or generate — a competitive bid. Veterinary consolidator ownership in 2026 looks like a landscape of financial buyers, each with fund cycles, acquisition mandates, and exit timelines that make some buyers hungrier than others at any given moment.
This page maps the ownership structure behind the major platforms, verified to primary sources — PE portfolio pages, press releases, AVMA reporting, and company disclosures. For the full directory of active consolidators and their footprints, see our veterinary practice consolidators guide.
For how multiples and deal structure work across these buyers, see how much private equity is paying for veterinary practices. Here we focus on one question: who owns whom, and why that matters.
Who are the PE sponsors behind the major veterinary consolidators in 2026?
The largest veterinary consolidators in 2026 are owned by private equity or family capital — not the local vet who started the brand. Shore Capital Partners backs Mission Pet Health. JAB Holding Company owns NVA.
Oak Hill Capital (alongside Harvest Partners and Cressey & Company) backs VetCor. KKR owns PetVet Care Centers.
AEA Investors and ADIA back AmeriVet. TSG Consumer Partners owns Thrive Pet Healthcare (formerly Pathway Vet Alliance).
Mars Veterinary Health — VCA, Banfield, BluePearl — is the one major exception, family-owned by Mars, Inc. Each sponsor has different capital, different timelines, and different reasons to be aggressive or patient in any given quarter.
The ownership map below covers the platforms that show up most often in competitive processes for general companion-animal practices above $2 million in revenue.
The ownership map: PE sponsors behind the major platforms
| Consolidator | PE Sponsor / Owner | Approx. scale (US hospitals) | Notes |
|---|---|---|---|
| Mission Pet Health | Shore Capital Partners | 850+ | Post-merger brand; SVP + MVP merged late 2024, brand launched July 2025 |
| NVA (National Veterinary Associates) | JAB Holding Company | ~1,400 GP + equine | Split from Ethos 2023; GP and specialty now run as distinct entities |
| Ethos Veterinary Health | JAB Holding Company | ~145 specialty/ER | Spun out of NVA 2023; includes legacy Ethos, Compassion-First, SAGE |
| Mars Veterinary Health (VCA, Banfield, BluePearl) | Mars, Inc. (family-owned) | ~2,000+ (VCA 1,000+, Banfield 1,000+) | Not PE-backed; no fund life; strategic acquirer |
| VetCor | Oak Hill Capital Partners + Harvest Partners + Cressey & Company | 270+ | Oak Hill-led recap; CEO Dan Adams; community-practice focus |
| PetVet Care Centers | KKR | 400+ | KKR acquired from Ontario Teachers + L Catterton; $2.3B recapitalization 2023 |
| Thrive Pet Healthcare | TSG Consumer Partners | 300+ | Formerly Pathway Vet Alliance; TSG acquired from Morgan Stanley Capital Partners 2020 |
| AmeriVet Veterinary Partners | AEA Investors LP + ADIA | 200+ | $1.6B recap 2022; ADIA = Abu Dhabi Investment Authority sovereign wealth co-investor |
| Alliance Animal Health | L Catterton | 200+ | L Catterton Flagship Fund lead investor since 2022; LightBay retained minority |
| Heartland Veterinary Partners | Gryphon Investors | 100+ | Midwest and South focus; Gryphon made majority investment |
| Community Veterinary Partners (CVP) | OMERS | 75+ | OMERS = Ontario Municipal Employees Retirement System; Canadian institutional owner |
| Rarebreed Veterinary Partners | Revelstoke Capital Partners | 100+ | Northeast corridor; Trilantic Capital and Halle Capital also investors |
| Veterinary Practice Partners (VPP) | Pamlico Capital | 75+ | Mid-Atlantic and Southeast focus |
| United Veterinary Care | TA Associates | 75+ | TA is a growth equity firm; longer hold period than typical buyout PE |
*Note: Practice counts and ownership reflect the most recent publicly available disclosures as of mid-2026. Consolidator portfolios change frequently via acquisition.
For current practice-count data, see each consolidator’s corporate website.*
Mission Pet Health and Shore Capital: the 2025–2026 headline story
There is no bigger story in veterinary consolidator ownership in 2025–2026 than Mission Pet Health. It is the combined entity of Southern Veterinary Partners (SVP) and Mission Veterinary Partners (MVP), two Shore Capital Partners platforms that merged in late 2024.
The unified brand launched publicly on July 21, 2025, per the company’s own press release.
Shore Capital Partners is a Chicago-based private equity firm focused on micro-cap healthcare and other sectors. It backed SVP from the platform’s early stages and separately backed MVP.
The merger brought both portfolios under one operating company, creating a national network of more than 850 hospitals with over 20,000 teammates — one of the largest veterinary hospital networks in the country.
Mission Pet Health is actively acquiring practices across the country now. The focus, per the company’s own positioning, is on practices with strong clinical teams, geographic synergy with existing network locations, and leadership willing to stay engaged post-close.
For sellers thinking about what the ownership structure means: Shore Capital has invested heavily in growth via M&A, which suggests the platform is in acquisition mode, not harvesting mode.
For a deeper look at how Mission Pet Health approaches acquisitions, see our Mission Pet Health seller guide.
JAB Holding Company, NVA, and the Ethos split
NVA — National Veterinary Associates — is owned by JAB Holding Company, the Luxembourg-based family-controlled investment firm controlled by the Reimann family. JAB acquired NVA in June 2019 from Ares Management, and the platform has roughly tripled in scale since then.
The move that reshaped NVA’s structure came in March 2023. JAB announced it would split NVA into two distinct businesses:
- NVA — approximately 1,400 locations focused on general practice, equine, and pet resort operations (~$4 billion run-rate revenue at split)
- Ethos Veterinary Health — approximately 145 specialty and emergency hospitals, incorporating legacy Ethos (which NVA acquired via a $1.65 billion deal closed July 2022), Compassion-First, SAGE, and legacy NVA specialty hospitals (~$2 billion run-rate revenue)
The stated rationale was to allow each entity to focus on its distinct strategic priorities and prepare for eventual IPOs. JAB stated the split was designed to unlock value from each business independently.
The FTC required JAB to divest clinics in certain markets — Richmond, Virginia; Denver; San Francisco; and the Washington, D.C., area — as a condition of the Ethos acquisition, and also imposed prior-approval requirements on future JAB acquisitions of specialty and emergency clinics in those markets.
For sellers: the practical implication is that general practice sellers evaluate NVA as the acquirer, while specialty or emergency practice owners would interact with Ethos. Both remain JAB-owned.
Both are active buyers. And sellers considering rollover equity — keeping a stake in the platform post-close — should understand that the exit path JAB has described is an IPO, not a private sponsor-to-sponsor sale.
We discuss rollover equity and earnout structures in a separate guide.
Mars Veterinary Health: the strategic exception
Mars Veterinary Health is the one major consolidator in this market that is not PE-backed. It is owned by Mars, Inc., the private family company behind M&Ms, Pedigree, and Whiskas.
Mars is not a fund with a life. It does not have LPs waiting for a return.
It does not have to sell.
Mars operates three distinct veterinary brands in the US:
- VCA Animal Hospitals — over 1,000 general, specialty, and emergency locations in the US and Canada, plus locations in Japan. Mars acquired VCA in 2017 for approximately $9.1 billion.
- Banfield Pet Hospital — over 1,000 general practice locations, the majority inside PetSmart stores. Banfield was already part of Mars before the VCA acquisition.
- BluePearl Specialty and Emergency Pet Hospital — specialty and emergency network, operated under VCA’s structure.
Mars runs each brand as a distinct and separate business within its broader petcare operation. The parent is one of the largest private companies in the world by revenue, which gives Mars almost unlimited patient capital compared to any PE-backed platform.
That difference matters in the context of veterinary consolidator ownership for sellers. A PE-backed buyer typically needs a clean exit within 5 to 10 years.
Mars can hold indefinitely. For a seller thinking about what happens to their practice in 10 years — and to rollover equity in the acquiring entity — those are fundamentally different structures.
VetCor, PetVet, AmeriVet: the next tier of ownership structures
VetCor — Oak Hill, Harvest, Cressey
VetCor operates one of the largest networks of independently branded community veterinary practices in the US, with hundreds of locations across more than 25 states. The current ownership structure comes from a recapitalization led by Oak Hill Capital Partners, alongside significant investment from existing shareholders Harvest Partners and Cressey & Company, and the VetCor management team led by CEO Dan Adams.
VetCor’s model is deliberately community-practice-focused. It acquires practices that continue to operate under their local brand names and retain existing staff and culture.
For sellers thinking about identity post-close, that model is worth understanding — and it shapes the kind of practice and owner VetCor typically targets.
PetVet Care Centers — KKR
PetVet Care Centers is owned by KKR, the global alternative asset manager. KKR acquired PetVet from Ontario Teachers’ Pension Plan and L Catterton.
In 2023, KKR secured a $2.3 billion unitranche recapitalization for the platform, underscoring continued PE capital commitment to the business.
PetVet operates general practice and specialty hospitals. KKR’s involvement signals a well-capitalized platform with the institutional resources to continue acquisitions at scale.
AmeriVet — AEA Investors and ADIA
AmeriVet Veterinary Partners is backed by AEA Investors LP and a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA), the UAE sovereign wealth fund. AEA and ADIA completed a $1.6 billion recapitalization of AmeriVet in March 2022.
The ADIA co-investment is notable. Sovereign wealth capital alongside a traditional PE firm creates a different financial profile than a standard buyout — longer potential hold periods and a different return expectation from the ADIA piece specifically.
For sellers considering what the next 5 to 10 years look like for the platform they’re joining, that matters.
Thrive Pet Healthcare and the TSG Consumer story
Thrive Pet Healthcare — operating under what was formerly the Pathway Vet Alliance brand — is owned by TSG Consumer Partners, a San Francisco-based private equity firm focused on consumer brands. TSG acquired Pathway Vet Alliance from Morgan Stanley Capital Partners in April 2020.
In March 2025, Thrive completed a large-scale liability management exercise, including a debt exchange that extended maturities and added liquidity. The transaction was supported by all existing lenders and by TSG, the equity sponsor, signaling continued commitment to the platform.
The Thrive story illustrates one important dynamic for sellers thinking about veterinary consolidator ownership: platforms go through capital cycles, and what a platform looks like at acquisition may shift as debt matures and sponsors make refinancing decisions. A competitive process that surfaces multiple buyers — rather than a single-buyer direct approach — gives a seller visibility into which platforms are in active acquisition mode versus managing their balance sheet.
Alliance Animal Health, Heartland, and the middle-market tier
Several well-capitalized mid-tier platforms are also active buyers in 2026:
Alliance Animal Health received a significant growth investment from the Flagship Fund of L Catterton — the world’s largest consumer-focused private equity firm — in January 2022. LightBay Capital, which originally built the platform starting in 2019, retained a meaningful minority stake alongside L Catterton.
Alliance operates more than 200 partner practices across 27-plus states.
Heartland Veterinary Partners is backed by Gryphon Investors, a San Francisco-based middle-market PE firm. Gryphon took a majority stake in Heartland and has continued to support add-on acquisitions, particularly in the Midwest and Southern markets where Heartland’s footprint is concentrated.
Community Veterinary Partners (CVP) has a distinctly different ownership profile: it is backed by OMERS, the Ontario Municipal Employees Retirement System. Canadian pension-fund ownership means a longer-hold-period institutional orientation — more like the ADIA co-investor situation at AmeriVet than a traditional 5-year buyout fund timeline.
Rarebreed Veterinary Partners operates the Eastern Seaboard from Maine to Florida and is majority backed by Revelstoke Capital Partners, with Trilantic Capital Partners and Halle Capital also invested.
The full picture of more than 42 named active consolidators — including United Veterinary Care (TA Associates), Veterinary Practice Partners (Pamlico Capital), Innovetive PetCare (Metalmark Capital), Companion Pet Partners (Cortec Group), and others — is at our veterinary practice consolidators directory.
Why does the PE sponsor behind a consolidator matter when you’re selling?
A buyer’s name on an offer letter tells you who you’ll work with operationally. The PE sponsor tells you why they’re at the table.
PE firms operate on fund lifecycles — typically 5 to 10 years from when the capital is raised to when it needs to be returned. A platform at the early stage of its sponsor’s fund life has a mandate to deploy capital aggressively: acquire more practices, grow fast, prepare for an eventual sale or IPO at a higher multiple than entry.
That’s a favorable environment for sellers — platforms in growth mode tend to pay more competitively and move faster.
A platform nearing the end of its sponsor’s fund life is in a different posture. The sponsor is thinking about exit, not new acquisitions.
Offers from that platform, when they arrive, may still be competitive — but the urgency is different, and the post-close trajectory of any rollover equity the seller retains is tied to an exit that could happen relatively soon.
Multiple arbitrage is the underlying engine. Multiple arbitrage is the profit PE-backed buyers capture by acquiring smaller practices at lower EBITDA multiples, integrating them into a larger platform, then selling the combined platform at a higher multiple — because large platforms command better prices than individual practices. A $1 million EBITDA practice acquired at 8 times contributes $8 million to a platform that could eventually sell at 12 times for $12 million on that same EBITDA.
That $4 million gap is the sponsor’s gain, and it’s the reason PE buyers are willing to acquire at competitive prices: the math works even at high entry multiples, if the platform’s exit multiple is higher.
That dynamic is directly relevant to who to sell your veterinary practice to — a question that depends as much on where each sponsor is in its lifecycle as on the brand name of the platform.
What a competitive process reveals about buyer motivation
I’ve sat across the table from most of these platforms. The consistent pattern I see: when a seller runs a competitive process with multiple qualified buyers bidding simultaneously — not a series of one-at-a-time conversations — the ownership structure behind each buyer becomes immediately visible in their behavior.
A platform with fresh sponsor capital and an active mandate arrives motivated. The offer reflects urgency to deploy.
A platform managing its balance sheet arrives more carefully. The offer reflects caution.
Neither is bad. But knowing which you’re dealing with before you respond to an offer — or before you decide whether to seek competing offers — is the difference between negotiating from information and negotiating from hope.
Our Elite Selling System is the methodology we use to make that happen. We hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope controls who gets inside.
That vetted group then bids inside a structured competitive window, so the ownership map above becomes actionable: you see which sponsors are most motivated, in real time, through their actual offers.
Get a Free Practice Value Estimate →
If you want to understand what your practice is worth to the buyer pool described in this ownership map — and which sponsor-backed platform is likely to bid highest for your specific practice profile — a practice value estimate is the starting point.
We work on a success-based engagement model. No upfront fees, no retainer.
We get paid when a deal closes, and only out of the value created above what you would have realized on your own. That alignment means we’re only at the table when the outcome justifies it.
Frequently asked questions
Who are the major veterinary consolidators and their PE sponsors in 2026?
The major PE-sponsored platforms include Mission Pet Health (Shore Capital Partners), NVA and Ethos Veterinary Health (JAB Holding Company), VetCor (Oak Hill Capital Partners, Harvest Partners, Cressey & Company), PetVet Care Centers (KKR), AmeriVet Veterinary Partners (AEA Investors and ADIA), and Thrive Pet Healthcare (TSG Consumer Partners). Mars Veterinary Health — VCA, Banfield, and BluePearl — is family-owned by Mars, Inc. and not PE-backed.
What private equity firm owns NVA in 2026?
NVA is owned by JAB Holding Company, the Luxembourg-based family-controlled investment firm. JAB acquired NVA in 2019.
In 2023, JAB announced a split of NVA into two distinct businesses: NVA (general practice, equine, and pet resort; approximately 1,400 locations) and Ethos Veterinary Health (specialty and emergency; approximately 145 hospitals). Both entities remain JAB-owned, with IPOs described as the eventual exit path.
Who owns Mission Pet Health and what is its PE sponsor?
Mission Pet Health is backed by Shore Capital Partners. It is the post-merger entity of Southern Veterinary Partners (SVP) and Mission Veterinary Partners (MVP), both of which were Shore Capital platforms.
The merger closed in late 2024; the unified Mission Pet Health brand launched publicly in July 2025. With more than 850 hospitals nationwide, it is among the most active consolidators in the US market in 2025 and 2026.
Who backs VetCor and how many practices does it operate?
VetCor is backed by Oak Hill Capital Partners, which led a recapitalization alongside existing shareholders Harvest Partners and Cressey & Company. VetCor operates hundreds of independently branded community veterinary hospitals across the United States, with CEO Dan Adams leading the company.
The platform is specifically focused on community practices that continue to operate under their local brand names after acquisition.
Is Mars Veterinary Health a private equity company?
No. Mars Veterinary Health — which includes VCA Animal Hospitals, Banfield Pet Hospital, and BluePearl — is owned by Mars, Inc., the private family company.
Mars is not a PE firm and has no fund life or return-of-capital mandate. VCA was acquired by Mars in 2017 for approximately $9.1 billion.
Mars operates nearly 3,000 veterinary hospitals globally across all three brands.
What does it mean for a seller that a consolidator is PE-backed?
PE-backed buyers operate on fund lifecycles — typically 5 to 10 years — during which the sponsor needs to acquire, grow, and eventually exit. That timeline creates urgency to deploy capital during the acquisition phase, which generally produces competitive offers for quality practices.
It also means the platform will be sold or taken public at some point, which affects what post-close governance and any rollover equity stake look like over time.
Why does the PE sponsor behind a consolidator matter when you’re selling?
The sponsor determines capital availability, acquisition appetite, timeline pressure, and the platform’s likely exit. A platform with a fresh recapitalization and an active sponsor is typically more motivated to acquire — and to offer competitive terms — than one nearing the end of its fund life.
Sellers considering rollover equity should understand the sponsor’s track record and stated exit path before committing.
How many veterinary consolidators are actively acquiring practices in 2026?
TE’s Lead Verifier pipeline has identified more than 42 named consolidators actively acquiring in the US market. The top tier — Mission Pet Health, NVA, Mars, VetCor, PetVet, Thrive, AmeriVet, Alliance Animal Health — operates at national or near-national scale.
Dozens of smaller platforms acquire at regional or state-level scale. The full directory is at transitionselite.com/veterinary-practice-consolidators/.
Sources
Industry M&A research and valuation data
- Capstone Partners. “Pet Sector M&A Update — April 2026.” capstonepartners.com
- Today’s Veterinary Business. “The Great Compression, Year 3: Capital Year in Review.” December 2025. todaysveterinarybusiness.com
- Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion; VSOs Under Increasing Pressure.” octus.com
Public company disclosures and PE portfolio filings
- Mission Pet Health. “Southern Veterinary Partners and Mission Veterinary Partners Join Together as Mission Pet Health.” Press release, July 21, 2025. missionpethealth.com
- Shore Capital Partners. “Mission Pet Health.” Portfolio page. shorecp.com
- BusinessWire. “NVA, the Leading Global Pet Healthcare Organization, to Form Two Distinct Veterinary Businesses.” March 27, 2023. businesswire.com
- JAB Holding Company. “Ares Management Agrees to Sell NVA.” Press release. jabholco.com
- Harvest Partners. “VetCor.” Portfolio page. harvestpartners.com
- Paul, Weiss. “Oak Hill Capital Leads Recapitalization of VetCor.” paulweiss.com
- Today’s Veterinary Business. “Deep-pocketed KKR buys PetVet chain.” todaysveterinarybusiness.com
- BusinessWire. “AmeriVet Veterinary Partners Acquired by AEA Investors LP and ADIA from Imperial Capital.” March 7, 2022. businesswire.com
- AEA Investors. “AmeriVet Partners Management, Inc.” Portfolio page. aeainvestors.com
- TSG Consumer Partners. “Thrive Pet Healthcare.” Portfolio page. tsgconsumer.com
- PR Newswire. “Thrive Pet Healthcare Secures New Financing Providing $350+ Million of Enhanced Liquidity.” March 2025. prnewswire.com
- PR Newswire. “Alliance Animal Health Receives Significant Growth Investment from L Catterton.” January 2022. prnewswire.com
- Gryphon Investors. “Heartland Veterinary Partners.” Portfolio page. gryphon-inv.com
Veterinary profession and regulatory data
- AVMA. “NVA splits into two businesses, may go public in next few years.” avma.org
- dvm360. “Merger of veterinary organizations yields a new name.” dvm360.com
- Mars Veterinary Health. “Our Companies.” marsveterinary.com
- Mars, Incorporated. “Mars, Incorporated to Acquire VCA Inc.” Press release, 2017. mars.com
Melani Seymour, co-founder of Transitions Elite, helps veterinary practice owners take action now to maximize value and secure their future.
With over 15 years of experience guiding thousands of owners, she knows exactly what it takes to achieve the best outcome.
Ready to see what your practice is worth?
